Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: CARDINAL HEALTH AT PALMS OF PASADENA HOSPITAL

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of CARDINAL HEALTH AT PALMS OF PASADENA HOSPITAL in 1501 PASADEN AVE S., ST PETERSBURG, FL 33707 (NAICS 622110). OSHA activity number 306769746.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Cardinal Health at Palms of Pasadena Hospital — free Get an email when a new federal OSHA severe-injury report for Cardinal Health at Palms of Pasadena Hospital is published. One employer, no account, unsubscribe in one click.
Site address
1501 PASADEN AVE S.
City
ST PETERSBURG
State
FL
ZIP
33707
Mailing
1501 PASADEN AVE S., ST PETERSBURG, FL 33707
Inspection type
Complaint (B)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
N
Opened
Closing conference
Case closed
Data loaded
NAICS code
622110
SIC code (legacy)
8062
Employees
800
Ownership type
A

1 citation on file for this inspection.

5(a)(1)

Serious Gravity 10 1 instance 4 exposed
Issued
Oct 22, 2003
Abate by
Dec 10, 2003
Penalty
Initial $4,500 · Current $3,300 Reduced
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The
employer did
not furnish employment and a palace of employment which were free from
recognized
hazards that were causing or likely to cause death or serious physical
harm to
employees in that employees in that employees were exposed to the hazard of
exposure to cytotoxic/antineoplastic drugs.
a) The employer did not ensure that health care workers working with
cytotoxic
drugs/antineoplastic drugs such as but not limited to adrucil-5
fluorouracil,
adriamycin-Doxorubicin,Bienoxane-Bleomycin, Cytoxan- Cyclophosphamide and
Fludara-Fludarabine were following work practices to minimize exposure to
the
drugs, in that, the top of a sharps container was removed, the sharp
container was
filled to the top with needles and syringes that were contaminated with
hazardous
drugs and the sharps container was stored in the laminar flow hood.
Among other methods, one feasible and acceptable abatement to correct this
hazard is
to place needles contaminated with hazardous drugs in an appropriate
puncture
resistant, leakproof on the sides top and bottom. Do not fill the sharps
container
beyond a point that would allow the sharps to fit entirely within the
container with the
top in place. Discontinue the storage of items in the laminar flow hood.
Recent events (2)
  • — I (S) $3300.00
  • — Z (S) $4500.00

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 306769746.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.